cannabinoid drugs for Dravet Syndrome

2 tracked cannabinoid drugs in the Dravet Syndrome race. The class explanation lives on the cannabinoid page; the full indication pipeline across every mechanism is on the Dravet Syndrome page.

1 approved / phase 41 preclinical / unstaged

Head-to-head evidence: Cannabidiol (Epidiolex) vs Cannabidiol (Kanbis)

The roster

← all cannabinoid drugs